The economic burden of bipolar disorder in the United States: a systematic literature review
L Bessonova, K Ogden, MJ Doane… - ClinicoEconomics …, 2020 - Taylor & Francis
Bipolar disorder (BD) is a mood disorder with subtypes characterized by episodes of mania,
hypomania, and/or depression. BD is associated with substantial economic burden, and the …
hypomania, and/or depression. BD is associated with substantial economic burden, and the …
Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses
U McCormick, B Murray, B McNew - Journal of the American …, 2015 - journals.lww.com
Purpose: This review article provides an overview of the frequency, burden of illness,
diagnosis, and treatment of bipolar disorder (BD) from the perspective of the advanced …
diagnosis, and treatment of bipolar disorder (BD) from the perspective of the advanced …
[HTML][HTML] Treatment-adherence in bipolar disorder: a patient-centred approach
S Chakrabarti - World journal of psychiatry, 2016 - ncbi.nlm.nih.gov
About half of the patients diagnosed with bipolar disorder (BD) become non-adherent during
long-term treatment, a rate largely similar to other chronic illnesses and one that has …
long-term treatment, a rate largely similar to other chronic illnesses and one that has …
Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression
M Tohen, DP McDonnell, M Case, S Kanba… - The British Journal of …, 2012 - cambridge.org
BackgroundAtypical antipsychotics are widely used in bipolar mania. However, the efficacy
of atypical antipsychotics in bipolar depression has not been comprehensively explored …
of atypical antipsychotics in bipolar depression has not been comprehensively explored …
[HTML][HTML] Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments
MW Jann - American health & drug benefits, 2014 - ncbi.nlm.nih.gov
Background Patients with bipolar disorder are exceptionally challenging to manage
because of the dynamic, chronic, and fluctuating nature of their disease. Typically, the …
because of the dynamic, chronic, and fluctuating nature of their disease. Typically, the …
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
E Vieta, S Montgomery, AH Sulaiman… - European …, 2012 - Elsevier
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
M Greene, L Paladini, T Lemmer… - Neuropsychiatric …, 2018 - Taylor & Francis
Background Bipolar disorder type I (BD-I) is a chronic condition characterized by mania
episodes followed by syndromic recovery periods, usually permeated by depressive …
episodes followed by syndromic recovery periods, usually permeated by depressive …
Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization
Study Objective To estimate the impact of adherence to and persistence with atypical
antipsychotics on health care costs and risk of hospitalization by controlling potential …
antipsychotics on health care costs and risk of hospitalization by controlling potential …
Effect of long acting injectable antipsychotics on course and hospitalizations in bipolar disorder–a naturalistic mirror image study
E Yıldızhan, E Uzun, NB Tomruk - Nordic Journal of Psychiatry, 2022 - Taylor & Francis
Purpose To determining whether the addition of a long-acting injectable antipsychotic (LAI-
AP) has a positive effect on prognosis in bipolar disorder. Materials and methods Medical …
AP) has a positive effect on prognosis in bipolar disorder. Materials and methods Medical …
Reduction of healthcare costs through a transitions-of-care program
W Ni, D Colayco, J Hashimoto, K Komoto… - The Bulletin of the …, 2018 - academic.oup.com
Purpose Results of an evaluation of the impact of a pharmacy-based transitional care
program on healthcare costs in a population of high-risk patients are reported. Methods A …
program on healthcare costs in a population of high-risk patients are reported. Methods A …